STOCK TITAN

Renuvion Named #1 Trusted Body Contouring Technology by Doctors*

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Apyx Medical (NASDAQ: APYX) announced that Renuvion has been named the #1 trusted body contouring technology by doctors in an independent survey. This recognition highlights Renuvion's effectiveness in targeting loose skin for body contouring procedures. Key points include:

- Renuvion is the first and only technology targeting loose skin from the inside out
- 4 out of 5 surgeons prefer Renuvion over other treatments following liposuction
- Over 350,000 patients have been treated with Renuvion
- Apyx Medical has secured four FDA 510(k) clearances in the past two years
- Renuvion is the only FDA-cleared device for contracting subcutaneous tissue and for use after liposuction

This recognition underscores Apyx Medical's commitment to providing evidence-based outcomes through advanced technology in plastic surgery.

Apyx Medical (NASDAQ: APYX) ha annunciato che Renuvion è stata nominata la tecnologia di contorno corporeo più fidata dai medici in un sondaggio indipendente. Questo riconoscimento sottolinea l'efficacia di Renuvion nel mirare alla pelle flaccida per le procedure di contorno corporeo. I punti chiave includono:

- Renuvion è la prima e unica tecnologia che agisce sulla pelle flaccida dall'interno verso l'esterno
- 4 chirurghi su 5 preferiscono Renuvion rispetto ad altri trattamenti dopo la liposuzione
- Oltre 350.000 pazienti sono stati trattati con Renuvion
- Apyx Medical ha ottenuto quattro approvazioni 510(k) della FDA negli ultimi due anni
- Renuvion è l'unico dispositivo approvato dalla FDA per la contrazione del tessuto sottocutaneo e per l'uso dopo la liposuzione

Questo riconoscimento sottolinea l'impegno di Apyx Medical nel fornire risultati basati su evidenze attraverso tecnologie avanzate nella chirurgia plastica.

Apyx Medical (NASDAQ: APYX) anunció que Renuvion ha sido nombrada la tecnología de contorno corporal más confiable por médicos en una encuesta independiente. Este reconocimiento destaca la efectividad de Renuvion para tratar la piel suelta en procedimientos de contorno corporal. Los puntos clave incluyen:

- Renuvion es la primera y única tecnología que se dirige a la piel suelta desde adentro hacia afuera
- 4 de cada 5 cirujanos prefieren Renuvion sobre otros tratamientos tras la liposucción
- Más de 350,000 pacientes han sido tratados con Renuvion
- Apyx Medical ha obtenido cuatro autorizaciones 510(k) de la FDA en los últimos dos años
- Renuvion es el único dispositivo autorizado por la FDA para contraer el tejido subcutáneo y para su uso después de la liposucción

Este reconocimiento subraya el compromiso de Apyx Medical de proporcionar resultados basados en evidencia a través de tecnologías avanzadas en cirugía plástica.

Apyx Medical (NASDAQ: APYX)는 Renuvion이 독립 조사에서 의사들에 의해 가장 신뢰받는 바디 컨투어링 기술로 선정되었다고 발표했습니다. 이 인정은 바디 컨투어링 절차에서 느슨한 피부를 겨냥한 Renuvion의 효과를 강조합니다. 주요 내용은 다음과 같습니다:

- Renuvion은 피부를 내측에서 외측으로 타겟팅하는 첫 번째이자 유일한 기술입니다
- 5명의 외과의사 중 4명이 지방흡입 후 다른 치료법보다 Renuvion을 선호합니다
- 350,000명이 넘는 환자가 Renuvion으로 치료받았습니다
- Apyx Medical은 지난 2년간 4건의 FDA 510(k) 승인을 받았습니다
- Renuvion은 피하 조직 수축 및 지방흡입 후 사용하기 위해 FDA 승인을 받은 유일한 장치입니다

이 인식은 Apyx Medical이 플라스틱 수술에서 증거 기반 결과를 제공하기 위한 첨단 기술에 대한 헌신을 강조합니다.

Apyx Medical (NASDAQ: APYX) a annoncé que Renuvion a été nommée la technologie de remodelage corporel la plus fiable par des médecins dans une enquête indépendante. Cette reconnaissance souligne l'efficacité de Renuvion dans le traitement de la peau lâche pour les procédures de remodelage corporel. Les points clés incluent :

- Renuvion est la première et seule technologie ciblant la peau lâche de l'intérieur vers l'extérieur
- 4 chirurgiens sur 5 préfèrent Renuvion à d'autres traitements après une liposuccion
- Plus de 350 000 patients ont été traités avec Renuvion
- Apyx Medical a obtenu quatre autorisations 510(k) de la FDA au cours des deux dernières années
- Renuvion est le seul appareil approuvé par la FDA pour contracter le tissu sous-cutané et pour une utilisation après liposuccion

Cette reconnaissance souligne l'engagement d'Apyx Medical à fournir des résultats basés sur des preuves grâce à une technologie avancée en chirurgie plastique.

Apyx Medical (NASDAQ: APYX) gab bekannt, dass Renuvion in einer unabhängigen Umfrage von Ärzten als die vertrauenswürdigste Technologie zur Körperformung ausgezeichnet wurde. Diese Anerkennung hebt die Wirksamkeit von Renuvion bei der Behandlung von schlaffer Haut für Körperformungsverfahren hervor. Wichtige Punkte sind:

- Renuvion ist die erste und einzige Technologie, die gezielt schlaffe Haut von innen heraus behandelt
- 4 von 5 Chirurgen bevorzugen Renuvion gegenüber anderen Behandlungen nach einer Fettabsaugung
- Über 350.000 Patienten wurden mit Renuvion behandelt
- Apyx Medical hat in den letzten zwei Jahren vier FDA 510(k) Genehmigungen erhalten
- Renuvion ist das einzige von der FDA genehmigte Gerät zur Kontraktion des subkutanen Gewebes und zur Anwendung nach einer Fettabsaugung

Diese Anerkennung unterstreicht das Engagement von Apyx Medical, evidenzbasierte Ergebnisse durch fortschrittliche Technologie in der plastischen Chirurgie zu liefern.

Positive
  • Renuvion named #1 trusted body contouring technology by doctors in independent survey
  • 4 out of 5 surgeons prefer Renuvion over other treatments following liposuction
  • Over 350,000 patients treated with Renuvion to date
  • Secured four FDA 510(k) clearances in the past two years
  • Only FDA-cleared device for contracting subcutaneous tissue and for use after liposuction
Negative
  • None.

Independent survey reveals Renuvion is #1 trusted body contouring technology* with plastic and cosmetic surgeons.

CLEARWATER, Fla., Aug. 13, 2024 /PRNewswire/ -- Apyx® Medical Corporation (NASDAQ: APYX) ("Apyx Medical;" the "Company"), a leader in advanced energy technology and the manufacturer of Renuvion®, today announced that doctors named Renuvion as the #1 trusted body contouring technology in an independent survey by Wakefield Research.** This recognition underscores the effectiveness of Renuvion's novel technology that targets loose skin at the source, offering unparalleled results for body contouring procedures.

Renuvion is the first and only body contouring technology that empowers consumers to feel and look their best, from the inside out by targeting loose skin. Renuvion brings evidence-based medicine to plastic surgery and as such, has garnered a global fan base of respected plastic surgeons around the world.

"The plastic surgery industry is built on trust and results, which is why we are dedicated to providing surgeons with the best technology focused on precision, safety, and results backed by 90-plus clinical papers and the most peer-reviewed studies," said Charlie Goodwin, President and Chief Executive Officer. "We're proud to be the technology surgeons use and trust to provide durable, transformative outcomes for patients."

In the U.S., Renuvion is increasingly being used by plastic surgeons in a time when consumer demand for plastic surgeon-performed procedures continues to rise. Over the past two years, the Apyx Medical team has secured four FDA 510(k) clearances which highlights the company's commitment to providing evidence-based outcomes through advanced technology in the hands of plastic surgeons. Since Renuvion launched into market, more than 350,000 patients have been treated with Renuvion to change the way people feel physically, mentally, and emotionally.

In addition to being named the #1 trusted body contouring technology, 4 out of 5 surgeons prefer Renuvion over other treatments to follow liposuction, which, of the nearly 2.3 million cosmetic surgical procedures performed in 2023, was the number one most common.*** Renuvion is the only device that is FDA-cleared for contracting subcutaneous tissue and the only device that is FDA-cleared for use after liposuction, providing people with a proven solution for loose skin.

*In a survey where 4 out of 5 surgeons agree.
**Of 200 unaffiliated board certified or eligible cosmetic and plastic surgeons in the US.
***2023 ISAPS International Survey on Aesthetic/Cosmetic Procedures

About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people's lives through innovative products, including its Helium Plasma Platform Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website www.ApyxMedical.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/renuvion-named-1-trusted-body-contouring-technology-by-doctors-302220441.html

SOURCE Apyx Medical Corporation

FAQ

What is Renuvion's ranking in body contouring technology according to the recent survey?

According to an independent survey by Wakefield Research, Renuvion was named the #1 trusted body contouring technology by doctors.

How many FDA clearances has Apyx Medical (APYX) secured for Renuvion in the past two years?

Apyx Medical has secured four FDA 510(k) clearances for Renuvion in the past two years.

What percentage of surgeons prefer Renuvion over other treatments following liposuction?

4 out of 5 surgeons, or 80%, prefer Renuvion over other treatments following liposuction.

How many patients have been treated with Renuvion since its launch?

Since Renuvion's launch, more than 350,000 patients have been treated with the technology.

What unique FDA clearances does Renuvion hold for body contouring?

Renuvion is the only device FDA-cleared for contracting subcutaneous tissue and the only device FDA-cleared for use after liposuction.

Apyx Medical Corporation

NASDAQ:APYX

APYX Rankings

APYX Latest News

APYX Stock Data

36.72M
34.64M
17.99%
40.52%
0.82%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
CLEARWATER